Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, a 6% increase year-over-year, with GAAP diluted EPS rising 70% to $1.70. Full-year 2026 revenue reached $254.2 billion (up 14%), and non-GAAP diluted EPS increased 37% to $11.26. The company declared a regular quarterly dividend of $0.5158 per share, payable October 15, 2026, to shareholders of record on October 1, 2026. Additionally, the board approved a $5.0 billion incremental share repurchase authorization and completed an additional $350 million accelerated share repurchase. Cardinal Health provided fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth. Cardinal Health operates in the healthcare distribution industry, providing pharmaceuticals, medical supplies, and related services.

Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility on August 7, 2026, replacing its existing Five-Year Credit Agreement ($2.0 billion), 364-Day Credit Agreement ($1.0 billion), and Receivables Purchase Agreement ($1.0 billion). The new facility terminates on August 7, 2031, with an option to extend for up to two years, and requires a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00. No penalties were incurred upon termination of the prior facilities. Cardinal Health operates in the healthcare supply chain industry, providing medical products and services.

Cardinal Health appointed Anita Zielinski as its new Chief Accounting Officer, effective November 5, 2026, succeeding Mary Scherer who will remain in the role until that date. Ms. Zielinski joins from Baxter International, where she served as interim CFO and Chief Accounting Officer since March 2026. Her compensation package includes a $750,000 cash sign-on bonus and an initial grant of restricted share units valued at $1,000,000 to offset forfeited equity from her previous employer. Cardinal Health operates in the healthcare distribution industry.

Cardinal Health, Inc. issued a news release announcing its financial results for the quarter ended March 31, 2026. The company also held a webcast to discuss these results and its outlook for the fiscal year ending June 30, 2026.

Gregory B. Kenny will retire from the Board of Directors and his position as Board Chair effective March 20, 2026, with current director Patricia A. Hemingway Hall appointed as his successor. Additionally, Cardinal Health announced that it will release its third quarter fiscal 2026 earnings on April 30, 2026.

Cardinal Health, Inc. announced that Mary Scherer, Senior Vice President and Chief Accounting Officer, intends to retire in February 2027. The company will initiate a search for her successor, and Ms. Scherer will continue to serve in her current role until a replacement is identified and onboarded.